235 related articles for article (PubMed ID: 11487448)
1. Combination lipid-altering therapy: an emerging treatment paradigm for the 21st century.
Jacobson TA
Curr Atheroscler Rep; 2001 Sep; 3(5):373-82. PubMed ID: 11487448
[TBL] [Abstract][Full Text] [Related]
2. Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus Panel.
Shepherd J; Betteridge J; Van Gaal L;
Curr Med Res Opin; 2005 May; 21(5):665-82. PubMed ID: 15969866
[TBL] [Abstract][Full Text] [Related]
3. Niacin as a component of combination therapy for dyslipidemia.
Miller M
Mayo Clin Proc; 2003 Jun; 78(6):735-42. PubMed ID: 12934785
[TBL] [Abstract][Full Text] [Related]
4. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
Cziraky MJ; Watson KE; Talbert RL
J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
[TBL] [Abstract][Full Text] [Related]
5. Niacin for dyslipidemia: considerations in product selection.
McKenney J
Am J Health Syst Pharm; 2003 May; 60(10):995-1005. PubMed ID: 12789870
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy for dyslipidemia: safety and regulatory considerations.
Davidson MH
Am J Cardiol; 2002 Nov; 90(10B):50K-60K. PubMed ID: 12467940
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy and safety of extended-release niacin alone or with atorvastatin for lipid profile modification].
Li XP; Duan J; Zhao SP; Tan MY; Xu ZM; Zhang DQ
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(34):2399-403. PubMed ID: 17156651
[TBL] [Abstract][Full Text] [Related]
8. Niacin-ER and lovastatin treatment of hypercholesterolemia and mixed dyslipidemia.
Yim BT; Chong PH
Ann Pharmacother; 2003 Jan; 37(1):106-15. PubMed ID: 12503944
[TBL] [Abstract][Full Text] [Related]
9. Clinical update on the use of niacin for the treatment of dyslipidemia.
Berra K
J Am Acad Nurse Pract; 2004 Dec; 16(12):526-34. PubMed ID: 15645997
[TBL] [Abstract][Full Text] [Related]
10. New developments in the use of niacin for treatment of hyperlipidemia: new considerations in the use of an old drug.
Crouse JR
Coron Artery Dis; 1996 Apr; 7(4):321-6. PubMed ID: 8853585
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy for combined dyslipidemia.
Xydakis AM; Ballantyne CM
Am J Cardiol; 2002 Nov; 90(10B):21K-29K. PubMed ID: 12467937
[TBL] [Abstract][Full Text] [Related]
12. Management of hypercholesterolaemia in postmenopausal women.
Davidson MH; Maki KC; Karp SK; Ingram KA
Drugs Aging; 2002; 19(3):169-78. PubMed ID: 12027776
[TBL] [Abstract][Full Text] [Related]
13. Managing dyslipidemia in the high-risk patient.
Stein EA
Am J Cardiol; 2002 Mar; 89(5A):50C-57C. PubMed ID: 11900720
[TBL] [Abstract][Full Text] [Related]
14. Combination drug therapy for combined hyperlipidemia.
Guyton JR
Curr Cardiol Rep; 1999 Sep; 1(3):244-50. PubMed ID: 10980849
[TBL] [Abstract][Full Text] [Related]
15. The rationale for combination therapy.
Rosenson RS
Am J Cardiol; 2002 Nov; 90(10B):2K-7K. PubMed ID: 12467935
[TBL] [Abstract][Full Text] [Related]
16. Management of hypercholesterolaemia in the patient with diabetes.
Packard C; Olsson AG
Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606
[TBL] [Abstract][Full Text] [Related]
17. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
Nesto RW
Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
[TBL] [Abstract][Full Text] [Related]
18. Lovastatin and extended-release niacin combination product: the first drug combination for the management of hyperlipidemia.
Gupta EK; Ito MK
Heart Dis; 2002; 4(2):124-37. PubMed ID: 11975844
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy of dyslipidemia.
McKenney JM
Cardiovasc Drugs Ther; 2001 Sep; 15(5):413-22. PubMed ID: 11855660
[TBL] [Abstract][Full Text] [Related]
20. Optimal management of combined dyslipidemia: what have we behind statins monotherapy?
Tenenbaum A; Fisman EZ; Motro M; Adler Y
Adv Cardiol; 2008; 45():127-153. PubMed ID: 18230960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
